Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Ligong Lu, Hui Zhang, Meixiao Zhan, et al.
Science China Life Sciences (2020) Vol. 63, Iss. 12, pp. 1833-1849
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Development and application of therapeutic antibodies against COVID-19
Lin Ning, Hamza B. Abagna, Qianhu Jiang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1486-1496
Open Access | Times Cited: 57
Dynamics of antibody response to CoronaVac vaccine
Marcela Helena Gambim Fonseca, Tamiris de Fátima Goebel de Souza, Fernanda Montenegro de Carvalho Araújo, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2139-2148
Open Access | Times Cited: 54
Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
COVID‑19 vaccination and IgG and IgA antibody dynamics in healthcare workers
Sabina Zurac, Luciana Nichita, Bogdan Mateescu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 2
Open Access | Times Cited: 44
Current progress in the development of prophylactic and therapeutic vaccines
Tingting Li, Ciying Qian, Ying Gu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 679-710
Open Access | Times Cited: 31
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Manish Dhawan, Nanamika Thakur, Manish Sharma, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117936-117936
Closed Access
Stability of SARS-CoV-2 on the Surfaces of Three Meats in the Setting That Simulates the Cold Chain Transportation
Xiao-Li Feng, Bei Li, Hao-Feng Lin, et al.
Virologica Sinica (2021) Vol. 36, Iss. 5, pp. 1069-1072
Open Access | Times Cited: 27
A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options
Yuntao Liu, Lan Song, Nairen Zheng, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 9, pp. 1866-1880
Open Access | Times Cited: 21
Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing
Duško Lainšček, Vida Forstnerič, Veronika Mikolič, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges
Jasmin Hassan, Charlotte Haigh, Tanvir Ahmed, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1066-1066
Open Access | Times Cited: 20
Interface‐Guided Computational Protein Design Reveals Bebtelovimab‐Resistance Mutations in SARS‐CoV‐2 RBD: Correlation with Global Viral Genomes and Bebtelovimab‐Escape Mutations
Shweata Maurya, S Rajesh Kumar, Aditya K. Padhi
ChemistrySelect (2023) Vol. 8, Iss. 46
Closed Access | Times Cited: 6
The functional views on response of host rabbit post coronavirus vaccination via ACE2 PET.
Li Xiao, Jie Li, Pan Zhou, et al.
PubMed (2023) Vol. 13, Iss. 1, pp. 43-50
Closed Access | Times Cited: 5
Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives
Cassiano Martin Batista, Leonardo Foti
International Immunopharmacology (2021) Vol. 99, pp. 108036-108036
Open Access | Times Cited: 12
A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies
Helena Cerutti, Tommaso Bandini, Marinunzia Castria, et al.
Journal of Clinical Virology (2022) Vol. 147, pp. 105064-105064
Open Access | Times Cited: 8
Receipt of inactivated COVID-19 vaccine had no adverse influence on embryo implantation, clinical pregnancy and miscarriage in early pregnancy
Yapeng Wang, Xiulian Ren, Zhongwei Wang, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 11, pp. 2332-2334
Open Access | Times Cited: 8
Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance
Diwenxin Zhou, Shuai Zhao, Keting He, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Immunological characterization and comparison of children with COVID-19 from their adult counterparts at single-cell resolution
Ran Jia, Zifeng Li, Shiwen Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Association between thrombocytopenia and platelet profile with morbidity/mortality of severe and non-severe COVID-19 patients
Laya Jalilian Khave, Parisa Zafari, Ali Pirsalehi, et al.
Revista da Associação Médica Brasileira (2021) Vol. 67, Iss. 11, pp. 1670-1675
Open Access | Times Cited: 10
Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
Zi-Jun Ding, Xinhua Zhang, Hai Li
Translational Pediatrics (2022) Vol. 11, Iss. 9, pp. 1544-1551
Open Access | Times Cited: 5
Peptide microarray analysis of in-silico predicted B-cell epitopes in SARS-CoV-2 sero-positive healthcare workers in Bulawayo, Zimbabwe
Arthur Vengesai, Tricia Naicker, Herald Midzi, et al.
Acta Tropica (2022) Vol. 238, pp. 106781-106781
Open Access | Times Cited: 5
Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2 (Delta) variant-infected patients
Zhiliang Hu, Yi Yin, Kai Wang, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2556-2559
Open Access | Times Cited: 4
Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq
Sevan Omer Majed
Cellular and Molecular Biology (2023) Vol. 69, Iss. 3, pp. 103-112
Open Access | Times Cited: 2
Simple workflow to repurpose SARS-CoV-2 swab/serum samples for the isolation of cost-effective antibody/antigens for proteotyping applications and diagnosis
Kerem Tok, Hichem Moulahoum, Faezeh Ghorbanizamani, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 413, Iss. 29, pp. 7251-7263
Open Access | Times Cited: 5
An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
Chunyun Sun, Hang Chi, Fei Yuan, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 165-179
Open Access | Times Cited: 3
The Critical Role of Pulse Oximetry Screening for Congenital Heart Disease and Patent Ductus Arteriosus in Newborns
Ioana Roşca, Daniela-Eugenia Popescu, Ana Maria Cristina Jura, et al.
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top